$74.78
0.03% today
NYSE, May 16, 03:45 pm CET
ISIN
US58933Y1055
Symbol
MRK

Merck & Co. Stock price

$74.80
-3.59 4.58% 1M
-21.51 22.33% 6M
-24.68 24.81% YTD
-56.93 43.22% 1Y
-17.52 18.98% 3Y
-1.27 1.67% 5Y
+17.37 30.24% 10Y
NYSE, Closing price Thu, May 15 2025
+1.33 1.81%
ISIN
US58933Y1055
Symbol
MRK
Sector
Industry

Key metrics

Market capitalization $187.83b
Enterprise Value $213.40b
P/E (TTM) P/E ratio 10.89
EV/FCF (TTM) EV/FCF 12.52
EV/Sales (TTM) EV/Sales 3.35
P/S ratio (TTM) P/S ratio 2.94
P/B ratio (TTM) P/B ratio 3.89
Dividend yield 4.17%
Last dividend (FY24) $3.12
Revenue growth (TTM) Revenue growth 4.40%
Revenue (TTM) Revenue $63.78b
EBIT (operating result TTM) EBIT $22.14b
Free Cash Flow (TTM) Free Cash Flow $17.04b
Cash position $9.33b
EPS (TTM) EPS $6.87
P/E forward 8.94
P/S forward 2.89
EV/Sales forward 3.28
Short interest 1.65%
Show more

Create a Free Account to create an Merck & Co. alert.

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

Merck & Co. Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Merck & Co. forecast:

15x Buy
58%
11x Hold
42%

Analyst Opinions

26 Analysts have issued a Merck & Co. forecast:

Buy
58%
Hold
42%

Financial data from Merck & Co.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
63,783 63,783
4% 4%
100%
- Direct Costs 16,147 16,147
7% 7%
25%
47,636 47,636
9% 9%
75%
- Selling and Administrative Expenses 5,586 5,586
14% 14%
9%
- Research and Development Expense 15,366 15,366
46% 46%
24%
26,684 26,684
200% 200%
42%
- Depreciation and Amortization 4,546 4,546
18% 18%
7%
EBIT (Operating Income) EBIT 22,138 22,138
341% 341%
35%
Net Profit 17,434 17,434
656% 656%
27%

In millions USD.

Don't miss a Thing! We will send you all news about Merck & Co. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Merck & Co. Stock News

Neutral
Business Wire
about 3 hours ago
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new clinical and outcomes research data on pulmonary arterial hypertension (PAH) to be presented at the American Thoracic Society's (ATS) 2025 International Conference in San Francisco from May 16-21. Data from nine presentations demonstrate Merck's commitment to advancing res...
Neutral
Business Wire
one day ago
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Positive Topline Results of Phase 3 KEYNOTE-B96 Trial In Patients With Platinum-Resistant Recurrent Ovarian Cancer.
More Merck & Co. News

Company Profile

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Head office United States
CEO Robert Davis
Employees 75,000
Founded 1891
Website www.merck.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today